THERESA MELDON: Open Payments
NPI 1013394808 · WEXFORD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,878 in 44 payments from 10 companies in 2025. Trend: 2023 $1,292 · 2024 $1,290 · 2025 $2,878
Food & beverage: $1,443Consulting: $1,350Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 25 | $2,061 |
| Madrigal Pharmaceuticals | 4 | $426 |
| ABBVIE INC. | 7 | $206 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $60 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Novo Nordisk Inc | 1 | $23 |
| Braintree Laboratories, Inc. | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
Products named: TREMFYA, REZDIFFRA, SKYRIZI, RINVOQ, ENTYVIO, EOHILIA, DUPIXENT, Wegovy.
Industry payments across PA — which companies pay providers there.
